- $27.27bn
- $34.52bn
- $53.72bn
- 96
- 94
- 70
- 98
2019 October 31st | 2020 October 31st | R2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K/A | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 58,756 | 56,639 | 63,460 | 62,910 | 53,718 |
Cost of Revenue | |||||
Gross Profit | 11,170 | 10,437 | 13,407 | 12,263 | 11,508 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 54,879 | 53,217 | 55,813 | 58,351 | 50,155 |
Operating Profit | 3,877 | 3,422 | 7,647 | 4,559 | 3,563 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,523 | 3,231 | 7,568 | 4,324 | 2,937 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,074 | 2,844 | 6,541 | 3,132 | 3,263 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3,152 | 2,844 | 6,541 | 3,132 | 3,263 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3,152 | 2,844 | 6,541 | 3,132 | 3,263 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.15 | 2.32 | 3.97 | 3.37 | 3.69 |
Dividends per Share |